Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands |
Total |
Common Stock |
Additional Paid-in Capital |
Retained Earnings |
Accumulated Other Comprehensive Loss |
Treasury Stock |
| Balance, at start of period (in shares) at Jan. 29, 2022 |
|
3,354,000
|
|
|
|
|
| Balance, at start of period at Jan. 29, 2022 |
$ 1,308
|
$ 47
|
$ 220,967
|
$ 77,093
|
$ 0
|
$ (296,799)
|
| Balance, at start of period, treasury stock (in shares) at Jan. 29, 2022 |
|
|
|
|
|
1,328,000
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Net loss |
(11,914)
|
|
|
(11,914)
|
|
|
| Exercise of stock options and vesting of restricted stock (in shares) |
|
76,000
|
|
|
|
(76,000)
|
| Exercise of stock options and vesting of restricted stock |
0
|
|
(5,038)
|
(11,935)
|
|
$ 16,973
|
| Share-based compensation |
2,393
|
|
2,393
|
|
|
|
| Repurchase of common stock (in shares) |
|
29,000
|
|
|
|
29,000
|
| Repurchase of common stock |
(1,890)
|
|
|
|
|
$ (1,890)
|
| Balance, at end of period (in shares) at Apr. 30, 2022 |
|
3,401,000
|
|
|
|
|
| Balance, at end of period at Apr. 30, 2022 |
(10,103)
|
$ 47
|
218,322
|
53,244
|
0
|
$ (281,716)
|
| Balance, at end of period, treasury stock (in shares) at Apr. 30, 2022 |
|
|
|
|
|
1,281,000
|
| Balance, at start of period (in shares) at Jan. 29, 2022 |
|
3,354,000
|
|
|
|
|
| Balance, at start of period at Jan. 29, 2022 |
1,308
|
$ 47
|
220,967
|
77,093
|
0
|
$ (296,799)
|
| Balance, at start of period, treasury stock (in shares) at Jan. 29, 2022 |
|
|
|
|
|
1,328,000
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Net loss |
$ (4,878)
|
|
|
|
|
|
| Repurchase of common stock (in shares) |
0
|
|
|
|
|
|
| Balance, at end of period (in shares) at Jul. 30, 2022 |
|
3,412,000
|
|
|
|
|
| Balance, at end of period at Jul. 30, 2022 |
$ (513)
|
$ 47
|
220,306
|
58,245
|
0
|
$ (279,111)
|
| Balance, at end of period, treasury stock (in shares) at Jul. 30, 2022 |
|
|
|
|
|
1,270,000
|
| Balance, at start of period (in shares) at Apr. 30, 2022 |
|
3,401,000
|
|
|
|
|
| Balance, at start of period at Apr. 30, 2022 |
(10,103)
|
$ 47
|
218,322
|
53,244
|
0
|
$ (281,716)
|
| Balance, at start of period, treasury stock (in shares) at Apr. 30, 2022 |
|
|
|
|
|
1,281,000
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Net loss |
7,036
|
|
|
7,036
|
|
|
| Exercise of stock options and vesting of restricted stock (in shares) |
|
12,000
|
|
|
|
(12,000)
|
| Exercise of stock options and vesting of restricted stock |
0
|
|
(636)
|
(2,035)
|
|
$ 2,671
|
| Share-based compensation |
$ 2,620
|
|
2,620
|
|
|
|
| Repurchase of common stock (in shares) |
0
|
1,000
|
|
|
|
1,000
|
| Repurchase of common stock |
$ (66)
|
|
|
|
|
$ (66)
|
| Balance, at end of period (in shares) at Jul. 30, 2022 |
|
3,412,000
|
|
|
|
|
| Balance, at end of period at Jul. 30, 2022 |
$ (513)
|
$ 47
|
220,306
|
58,245
|
0
|
$ (279,111)
|
| Balance, at end of period, treasury stock (in shares) at Jul. 30, 2022 |
|
|
|
|
|
1,270,000
|
| Balance, at start of period (in shares) at Jan. 28, 2023 |
3,688,000
|
3,688,000
|
|
|
|
|
| Balance, at start of period at Jan. 28, 2023 |
$ 307,569
|
$ 50
|
229,573
|
355,736
|
0
|
$ (277,790)
|
| Balance, at start of period, treasury stock (in shares) at Jan. 28, 2023 |
1,265,000
|
|
|
|
|
1,265,000
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Net loss |
$ (73,427)
|
|
|
(73,427)
|
|
|
| Exercise of stock options and vesting of restricted stock (in shares) |
|
62,000
|
|
|
|
(62,000)
|
| Exercise of stock options and vesting of restricted stock |
0
|
|
(1,036)
|
(12,497)
|
|
$ 13,533
|
| Share-based compensation |
1,871
|
|
1,871
|
|
|
|
| Repurchase of common stock (in shares) |
|
21,000
|
|
|
|
21,000
|
| Repurchase of common stock |
(354)
|
|
|
|
|
$ (354)
|
| Balance, at end of period (in shares) at Apr. 29, 2023 |
|
3,729,000
|
|
|
|
|
| Balance, at end of period at Apr. 29, 2023 |
$ 235,659
|
$ 50
|
230,408
|
269,812
|
0
|
$ (264,611)
|
| Balance, at end of period, treasury stock (in shares) at Apr. 29, 2023 |
|
|
|
|
|
1,224,000
|
| Balance, at start of period (in shares) at Jan. 28, 2023 |
3,688,000
|
3,688,000
|
|
|
|
|
| Balance, at start of period at Jan. 28, 2023 |
$ 307,569
|
$ 50
|
229,573
|
355,736
|
0
|
$ (277,790)
|
| Balance, at start of period, treasury stock (in shares) at Jan. 28, 2023 |
1,265,000
|
|
|
|
|
1,265,000
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Net loss |
$ (117,483)
|
|
|
|
|
|
| Repurchase of common stock (in shares) |
0
|
|
|
|
|
|
| Balance, at end of period (in shares) at Jul. 29, 2023 |
3,745,000
|
3,745,000
|
|
|
|
|
| Balance, at end of period at Jul. 29, 2023 |
$ 185,916
|
$ 50
|
224,513
|
222,435
|
0
|
$ (261,082)
|
| Balance, at end of period, treasury stock (in shares) at Jul. 29, 2023 |
1,208,000
|
|
|
|
|
1,208,000
|
| Balance, at start of period (in shares) at Apr. 29, 2023 |
|
3,729,000
|
|
|
|
|
| Balance, at start of period at Apr. 29, 2023 |
$ 235,659
|
$ 50
|
230,408
|
269,812
|
0
|
$ (264,611)
|
| Balance, at start of period, treasury stock (in shares) at Apr. 29, 2023 |
|
|
|
|
|
1,224,000
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Net loss |
(44,056)
|
|
|
(44,056)
|
|
|
| Exercise of stock options and vesting of restricted stock (in shares) |
|
16,000
|
|
|
|
(16,000)
|
| Exercise of stock options and vesting of restricted stock |
0
|
|
(214)
|
(3,321)
|
|
$ 3,535
|
| Share-based compensation |
$ (5,681)
|
|
(5,681)
|
|
|
|
| Repurchase of common stock (in shares) |
0
|
|
|
|
|
|
| Repurchase of common stock |
$ (6)
|
|
|
|
|
(6)
|
| Balance, at end of period (in shares) at Jul. 29, 2023 |
3,745,000
|
3,745,000
|
|
|
|
|
| Balance, at end of period at Jul. 29, 2023 |
$ 185,916
|
$ 50
|
$ 224,513
|
$ 222,435
|
$ 0
|
$ (261,082)
|
| Balance, at end of period, treasury stock (in shares) at Jul. 29, 2023 |
1,208,000
|
|
|
|
|
1,208,000
|